IMS Health Inc. (RX:US) surged 23 percent to $20.73 for the biggest gain in the S&P 500. The provider of prescription data to drugmakers and analysts, agreed to sell itself to investment funds managed by TPG Capital and the CPP Investment Board for $22 a share, or about $5.2 billion.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.